Objective To analyze clinical distribution and drug resistance of Acinetobacter baumannii isolated in Tungwah Hospital, to learn β-lactamase gene of Acinetobacter baumannii resistant to Carbapenem so as to provide the basis for clinical use of drugs and prevention of nosocomial infections. Methods Thirty strains of non-repetitive Acinetobacter baumannii resistant to Carbapenem which were isolated in Tungwah Hospital from January 2011 to December 2013 were collected. Agar dilution method was used to detect the minimal inhibitory concentrations (MIC) of 11 kinds of antimicrobial agents. Pidemiological analysis was conducted. Carbapenemase was screened by modified Hodge test. The metalloenzyme phenotype and AmpC enzyme phenotype of the tested strains were detected by EDTA-disk synergy test and three-dimensional test respectively. PCR amplification of , O and pulsed field gel electrophoresis (PFGE) homology analysis were used to analyze the moleculer type and genetic relationship between the resistant strains. Results In the 14 antimicrobial agents with monitored MIC, the resistance rate of 13 species was over 60%,only that of SCF was lower than 50%. Totally 30 strains of Carbapenem-resistant Acinetobacter baumannii were screened out, of which the metalloenzyme phenotype and gene were both negative, 21 strains had AmpC enzyme and 24 strains showed positive modified Hodge test; among which gene was amplified in 26 strains while gene was not detected. Conclusions The resistance of Acinetobacter baumannii isolated in clinic of Dongguan area is very severe. gene is the main carbapenemase gene, and Carbapenemresistant strains are prevalent in this area.